Growth Metrics

Dexcom (DXCM) Cash from Operations Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -7.20%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 132.40%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 6.69%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -35.67%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -84.38%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 122.43%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 185.96%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 16.00%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 28.60%
10 Zimmer Biomet Holdings 16.17 Bn 15.75 Bn 1.51 Bn -6.11%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 185.96%
Dec 31, 2025 -2.46%
Sep 30, 2025 230.78%
Jun 30, 2025 8.45%
Mar 31, 2025 -12.14%
Dec 31, 2024 125.60%
Sep 30, 2024 -25.89%
Jun 30, 2024 46.82%
Mar 31, 2024 34.62%
Dec 31, 2023 0.83%
Sep 30, 2023 -8.19%
Jun 30, 2023 10.13%
Mar 31, 2023 118.87%
Dec 31, 2022 25.24%
Sep 30, 2022 18.56%
Jun 30, 2022 180.52%
Mar 31, 2022 155.40%
Dec 31, 2021 -38.49%
Sep 30, 2021 67.55%
Jun 30, 2021 -60.03%
Mar 31, 2021 1,363.16%
Dec 31, 2020 19.69%
Sep 30, 2020 56.19%
Jun 30, 2020 138.91%
Mar 31, 2020 -83.90%
Dec 31, 2019 326.41%
Sep 30, 2019 66.37%
Jun 30, 2019 55.80%
Mar 31, 2019 235.63%
Dec 31, 2018 -18.20%
Sep 30, 2018 56.91%
Jun 30, 2018 189.51%
Mar 31, 2018 -3,000.00%
Dec 31, 2017 209.77%
Sep 30, 2017 57.39%
Jun 30, 2017 -28.86%
Mar 31, 2017 250.00%
Dec 31, 2016 17.70%
Sep 30, 2016 28.49%
Jun 30, 2016 22.56%
Mar 31, 2016 -105.88%
Dec 31, 2015 34.52%
Sep 30, 2015 57.02%
Jun 30, 2015 164.52%
Mar 31, 2015 241.67%
Dec 31, 2014 90.91%
Sep 30, 2014 612.50%
Jun 30, 2014 588.89%
Mar 31, 2014 46.67%
Dec 31, 2013 141.51%
Sep 30, 2013 126.67%
Jun 30, 2013 114.29%
Mar 31, 2013 55.88%
Dec 31, 2012 8.18%
Sep 30, 2012 10.99%
Jun 30, 2012 -149.41%
Mar 31, 2012 -9.81%
Dec 31, 2011 14.41%
Sep 30, 2011 28.82%